Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tsuyoshi Otsuji, Kenichiro Sho, Akiko Tsumura, Naoko Koike, Tetsuya Nishimura & Kanji Takahashi. (2016) Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions. Clinical Ophthalmology 10, pages 431-436.
Read now
Read now
Articles from other publishers (18)
Sameer Iqbal, Manoj S, Narendra Meel & Unnikrishnan Nair. (2022) To compare the short-term efficacy and safety of combination therapy with standard fluence and reduced fluence PDT in polypoidal choroidal vasculopathy. Indian Journal of Clinical and Experimental Ophthalmology 8:4, pages 520-524.
Crossref
Crossref
Alexandros Rouvas, Nikolaos Gouliopoulos, Maria Douvali, Georgios Koutsocheras, Maria Theodorou, Nikolaos Bouratzis, Panagiota Bougatsou & Panagiotis Theodossiadis. (2021) One year outcomes of treat and extend and pro re nata (PRN) treatment regimens with aflibercept for polypoidal choroidal vasculopathy. European Journal of Ophthalmology 31:6, pages 2868-2875.
Crossref
Crossref
Franco Manzur Yarur, Victor Meza V, Rodolfo Garretón C & Aldo Muñoz Q. (2021) Addition of photodynamic therapy to anti-vascular endothelial growth factor drugs compared to anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy. Medwave 21:08, pages e8460-e8460.
Crossref
Crossref
Wei Kiong Ngo, Wai Kitt Chee, Colin S. Tan & Tock Han Lim. (2020) Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy. BMC Ophthalmology 20:1.
Crossref
Crossref
Adrian H. C. Koh. 2020. Choroidal Neovascularization. Choroidal Neovascularization
217
236
.
Erdem Eris & Esra Vural. (2019) Early retinal and choroidal effect of photodynamic treatment in patients with polypoidal choroidal vasculopathy with or without anti-vascular endothelial growth factor: An optical coherence tomography angiography study. Photodiagnosis and Photodynamic Therapy 25, pages 1-6.
Crossref
Crossref
Kelvin Yi Chong Teo, David M. Squirrell, Vuong Nguyen, Gayatri Banerjee, Amy Cohn, Daniel Barthelmes, Chui Ming Gemmy Cheung & Mark Gillies. (2019) A Multicountry Comparison of Real-World Management and Outcomes of Polypoidal Choroidal Vasculopathy. Ophthalmology Retina 3:3, pages 220-229.
Crossref
Crossref
Ian Y. Wong, Xuan Shi, Rita Gangwani, Lawrence P. Iu, Nicholas Fung, Qing Li, Alex L. K. Ng & Xiaoxin Li. (2018) ONE-YEAR RESULTS OF HALF- VERSUS STANDARD-DOSE PHOTODYNAMIC THERAPY COMBINED WITH RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY. Retina 38:4, pages 725-730.
Crossref
Crossref
Prashant Jain, Giridhar Anantharaman, Mahesh Gopalakrishnan & Anubhav Goyal. (2018) Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy. Indian Journal of Ophthalmology 66:8, pages 1119.
Crossref
Crossref
Wenlan Zhang & Dilraj S. Grewal. 2018. Vitreoretinal Disorders. Vitreoretinal Disorders
91
131
.
Jia Li, Jianhua Sun, Bing Li & Zheli Liu. (2017) Intravitreal ranibizumab injection combined with photodynamic therapy for polypoidal choroidal vasculopathy. Experimental and Therapeutic Medicine.
Crossref
Crossref
Colin S. Tan, Wei Kiong Ngo, Louis W. Lim, Nikolle W. Tan & Tock H. Lim. (2016) EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study. Graefe's Archive for Clinical and Experimental Ophthalmology 254:10, pages 1923-1930.
Crossref
Crossref
Chee Wai Wong, Yasuo Yanagi, Won-Ki Lee, Yuichiro Ogura, Ian Yeo, Tien Yin Wong & Chui Ming Gemmy Cheung. (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Progress in Retinal and Eye Research 53, pages 107-139.
Crossref
Crossref
Parveen Sen, Muna Bhende, Ramya Sachidanandam, Nishat Bansal & Tarun Sharma. (2016) Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population. Indian Journal of Ophthalmology 64:12, pages 908.
Crossref
Crossref
Ian Y. Wong, Xuan Shi, Rita Gangwani, Paul Zhao, Lawrence P. Iu, Qing Li, Alex Ng & Xiaoxin Li. (2015) 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy. BMC Ophthalmology 15:1.
Crossref
Crossref
Colin S. Tan, Tock Han Lim & Seenu M. Hariprasad. (2015) Current Management of Polypoidal Choroidal Vasculopathy. Ophthalmic Surgery, Lasers and Imaging Retina 46:8, pages 786-791.
Crossref
Crossref
Chee Wong, Tien Wong & Chui Cheung. (2015) Polypoidal Choroidal Vasculopathy in Asians. Journal of Clinical Medicine 4:5, pages 782-821.
Crossref
Crossref
Eduardo Amorim Novais, Emmerson Badaró, Caio Vinicius Saito Regatieri, Jay Duker & Pedro Paulo de Oliveira Bonomo. (2015) Regression of Drusen After Combined Treatment Using Photodynamic Therapy With Verteporfin and Ranibizumab. Ophthalmic Surgery, Lasers and Imaging Retina 46:2, pages 275-278.
Crossref
Crossref